ArticleBMC cancer2022

A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma after surgery: the HSCK-010 trial protocol.

Yun Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.